Based on the forecasted data, Business Enterprise R&D Expenditure in Human Health and Social Work Activities in Germany is set to increase from 2024 to 2028, rising steadily from 10.35 million to 12.18 million US Dollars PPP. In 2023, this expenditure stood at 10.0 million, representing a significant upward trend over the forecast period.

The year-on-year growth rates indicate a consistent increase of approximately 4.45% over the last two years. The compound annual growth rate (CAGR) from 2024 to 2028 is projected at approximately 4.13%, reflecting a robust growth outlook in this sector.

Future trends to watch for include:

Increased investment in digital health technologies as Germany continues to integrate AI and machine learning into healthcare practices.
A focus on personalized medicine and precision health, potentially driving further R&D expenditures.
Policy changes or government incentives aimed at fostering innovation in healthcare and social work sectors.